Dysregulation of PDGFR signaling is implicated in various pathologies, including cancers and fibrotic disorders.129,130 The delicate balance maintained by PDGFR can be disrupted by changes in the receptor or its ligands, or by the crosstalk between the pathways. The gene discussed is PDGFRB; the disease is cancer.